General mechanisms of autoimmune diseases;MALADIES AUTO-IMMUNES: MECANISMES GENERAUX

Medecine Therapeutique

Volumn 3, Issue 9, 1997, Pages 735-746

  Boitard, Christian ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYTOTOXIC ANTIBODY; RECEPTOR ANTIBODY; T LYMPHOCYTE RECEPTOR;

AUTOIMMUNITY; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; DIAGNOSIS; ETIOLOGY; GENETIC ASSOCIATION; HUMAN; HYPERSENSITIVITY; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE; REVIEW;

EID: 0030667304     PISSN: 12646520     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Sinha A.A , Lopez M.T., McDevitt H.O. 1990. Autoimmune diseases : the failure of self tolerance. Science 248 : 1380-1388.
2. Wilkin T.J. 1990. Receptor autoimmunity in endocrine disorders. N Engl J Med 323 : 1318-1324.
3. Boitard C., Carnaud C. 1997. Lessons from animal models regarding pathogenesis of insulin-dependent diabetes mellitus. In : Leslie R.D.G., ed. Frontiers of hormone research. Bâle: Karger, 109-130.
4. Olee T., et al. 1991. Molecular basis of an autoantibody-associated restriction fragment lenght polymorphism that confers susceptibility to autoimmune diseases. J Clin Invest 88 : 193-203.
5. Wucherpfennig K.W., Strominger J.L. 1995. Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules : a mechanism for MHC-linked susceptibility to human autoimmune diseases. J Exp Med 181 : 1597-1601.
6. Homo-Delarche F., Boitard C. 1996. Autoimmune diabetes : the role of the islets of Langerhans. Immunol Today 17 : 456-460.
7. Goverman J., et al. 1993. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous auto-immunity. Cell 72 : 551-560.
8. Katz J.D., et al. 1993. Following a diabetogenic T cell from genesis through pathogenesis. Cell 74 : 1089-1100.
9. Seligman M , Brouet J C. 1973. Antibody activity of human myeloma globulins. Semin Hemotol 10 : 163-177.
10. Tanchot C., Lemmonier F.A., Pérarneau B., Freitas A.A., Rocha B. 1997. Differential requirements for survival and proliferation of CD8 and memory T cells. Science 276 : 2057-2062.
11. Heath W.R., et al. 1992. Autoimmune diabetes as a consequence of locally produced interleukin-2. Nature 359 : 547-549.
12. Boitard C , et al. 1989 T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J Exp Med 169 : 1669-1680.
13. Sun D., et al. 1988. Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions. Nature 332 : 843-845.
14. +T lymphocytes induces diabetes in resistant biobreeding/Worcester (BB/W) rats. J Exp Med 166 : 461-465.
15. Gleeson P.A., Toh B.H., Van Driel I.R. 1996. Organ-specific autoimmunity induced by lymphopenia. Immunol Rev 149 : 97-125.
16. Sarvetnick N., et al. 1990. Loss of pancreatic islet tolerance induced by beta-cell expression of interferongamma. Nature 346 : 844-847.
17. Lo D. 1996. Transgenic and knock out models of auto-immunity : building a better disease ? Clin Immunol Immunopathol 79 : 96-104.
18. Scott B., et al. 1994. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity 1 : 73-82.
19. Goldman M., Druet P , Gleichmann E. 1991. TH2 cells in systemic autoimmunity : insights from allogeneic diseases and chemically-induced autoimmunity. Immunol Today 12 : 223-227.
20. Romagnani S. 1996. TH1 and TH2 in human diseases. Clin Immunol Immunopathol 80 225-235
21. Shoenfeld Y., Mozes E. 1990. Pathogenic idiotypes of autoantibodies in autoimmunity : lessons from new experimental models of SLE. FASEB J 4: 2646-2651.
22. Wassermann N.H., et al. 1982. Anti-idiotypic route to anti-acetylcholine receptor antibodies and experimental myasthenia gravis. Proc Natl Acad Sci USA 79 : 4810-4814.
23. Sultan Y., et al. 1984. Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high dose intravenous gammaglobulin. Lancet ii : 765-768.
24. Conrad B., et al, 1994. Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature 371 : 351-355.
25. Leung D.Y., et al. 1995. Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis. J Clin Invest 96 : 2106-2112.
26. Lanzavecchia A. 1995. How can cryptic epitopes trigger autoimmunity. J Exp Med 181 : 1945-1948.
27. Ohashi P.S., et al. 1991. Ablation of « tolerance » and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65 : 305-317
28. Oldstone M.B., Nerenberg M., Southern P., Price J., Lewicki H. 1991. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model : role of anti-self [virus] immune response. Cell 65 : 319-331.
29. Von Herrath M.G., Evans C.F., Horwitz M.S., Oldston M.B.A. 1996. Using transgenic mouse models to dissect the pathogenesis of virus-induced autoimmune disorders of the islets of Langerhans and the central nervous system, Immunol Rev 152 111-141.
30. Bohme J., Schuhbaur B , Kanagawa O., Benoist C , Mathis D 1990. MHC-linked protection from diabetes dissociated from clonal deletion of T cells. Science 249 : 293-295.
31. Markman J., Lo D., Naji A., Palmifer R.D., Brinster R.L., Heber-Katz E. 1988. Antigen-presenting fonction of class II MHC expressing pancreatic beta cells. Nature 336 : 476-479.
32. Smith S.C., Allen P.M. 1992. Expression of myosin-class II major histocompatibility complexes in the normal myocardium occurs before induction of autoimmune myocarditis. Proc Natl Acad Sci USA 89 : 9131-9135.
33. Mamula M.J. 1995. Lupus autoimmunity : from peptides to particles, Immunol Rev 144 : 301-314.
34. Adams I.E., Alpert S., Hanahan D 1987. Non-tolerance and autoantibodies to a transgenic self antigen expressed in pancreatic beta cells. Nature 325 : 223-228.
35. Amrani A., et al. 1996. Interleukin-1 effect on glycemia in the non-obese diabetic mouse at the prediabetic stage. J Endocrinol 148 : 139-148.
36. Larger E., Becourt C., Bach J.F., Boitard C. 1995. Pancreatic islet beta cells drive T cell-immune responses in the nonobese diabetic mouse model. J Exp Med 181 : 1635-1642.
37. Pontes de Carvalho L.C., Templeman J., Wick G , Roitt I.M. 1982. The role of self-antigen in the development of autoimmunity in obese strain chickens with spontaneous autoallergic thyroiditis. J Exp Med 155 : 1255-1266.
38. Brown T.R., et al. 1991. Uptake and metabolism of iodine is crucial for the development of thyroiditis in obese strain chickens. J Clin Invest 88 : 106-111.
39. Atkinson M.A., Maclaren N.K., Luchetta R. 1990. Insulitis and diabetes in NOD mice are reduced by prophylactic insulin therapy. Diabetes 39 : 933-937.
40. Kennedy G.C., German M.S., Rutter W.J. 1995. The minisatellite in the diabetes susceptibility locus IDDM2 regulates insulin transcription. Nature Genet 9 : 293-298.
41. Rieut-Laucat F., et al. 1995. Mutations in Fas-associated with human lymphoproliferative syndrome and autoimmunity. Science 268 : 1759-1762.
42. Wu J., Wilson J., Xiang L., Schur P.H., Mountz J.D. 1996. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest 98 : 1107-1113
43. Golten H.R., Rosen F.S. 1992. Complement deficiencies. Ann Rev Immunol 10 : 809-834.
44. Claudy A. 1996. Pemphigoïde gestationis. Médecine thérapeutique 2 : 211-215.
45. Beaune P., Dansette P.M., Mansuy D., Kiffel L. 1987. Human antiendoplosmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a liver p-450 that hydroxylates the drug. Proc Natl Acad Sci USA 84 : 551-555.
46. Burlingame R.W., Rubin R.L 1991 Drug-induced anti-histone autoantibodies display two pattern of reactivity with substructures of chromatin. J Clin Invest 88 : 680-690.